openPR Logo
Press release

Fragment-Based Drug Discovery Market 2020 | What will be the market size and the growth rate by 2026?

01-16-2020 08:52 AM CET | Science & Education

Press release from: Straits Research

Fragment-Based-Drug-Discovery-Market

Fragment-Based-Drug-Discovery-Market

Trends Towards Fragment-Based Drug Discovery Market

The new research report on Fragment-Based Drug Discovery Market published by Straits Research is committed to delivering details analysis of the market. Straits Research offers a high level of accuracy, an in-depth valuation, and systematic research methodology to the reader that helped to collect the info from direct as well as indirect sources. Forecasting patterns were considered across the various regions where the Fragment-Based Drug Discovery industry is growing steadily. The report has taken a deep dive into the market and has extracted the data from secondary and primary sources.

While studying the worldwide markets for the Fragment-Based Drug Discovery, The report also provides details analysis of the market drivers, trends and restraints to showcase the current and future market scenario. Straits Research has ensured to provide a full-proof report that consists of the market strategies based on advanced technologies, applications, and different regions around the globe. The markets are expected to show significant growth during the forecasted period due to the increasing demand for the Fragment-Based Drug Discovery.

Get access to report sample @ https://straitsresearch.com/report/Fragment-Based-Drug-Discovery-Market/request-sample

The market is segmented into different sections such as by type, by application, by end-users, and by regions. The report about the Fragment-Based Drug Discovery covered the markets by analyzing the top players participating in the market. To make this report an exceptional one, several parameters are models are used which include SWOT analysis, Porter's five force model, and pestle analysis.

Development in technology and innovations have created an educated workforce that ultimately witnessed increasing per capita income and this particular factor has positively impacted the growth of the Fragment-Based Drug Discovery market for the past few years.

Top Market Key Players:

Some of the major players in the fragment-based drug discovery market are, Astex Pharmaceuticals, Beactica AB, Charles River Laboratories International, Inc, Crown Bioscience, Inc., Evotec A.G, Kinetic Discovery Limited, Plexxikon Inc., Proteros Fragments GmbH, Sprint Bioscience, and Structure Based Design, Inc.

Segmentation of Fragment-Based Drug Discovery Market:

By Service Component, Fragment Screening , Biophysical Techniques , NMR Spectroscopy , DSF Assay , Fluorescence Polarization (FP) , Isothermal Titration Calorimetry (ITC) , X-ray Crystallography , Surface Plasmon Resonance , Mass Spectrometry , Capillary Electrophoresis , Other Biophysical Techniques , Non-biophysical Techniques , Fragment Optimization

By End User, Biopharmaceutical Companies , CROs , Academic and Research Institutions

Go For special offer price @ https://straitsresearch.com/report/Fragment-Based-Drug-Discovery-Market/special-pricing

The competitive landscape:

The competitive landscape of the Fragment-Based Drug Discovery market is a highly crucial section of the report that creates a firm portrait of the market’s key players and their rivalries. A reader can evaluate their position in the market by using this scale of reference, while extensively planning their future movements to counter the movements of the other players in the same areas. This segment provides updated details on companies profiles, business strategies, financial statistics, growth rate and the future scenario for the key leading players in the market, along with the ones that indicate the most positive growth rates.

Fragment-Based Drug Discovery Market Report Highlights:

Fragment-Based Drug Discovery market Dynamics (Trends, Drivers, Restraints)
SWOT Analysis
Distribution Channel Analysis
Import/Export Strategies
Product Benchmarking and Pricing Analysis of Key Industry Players
Policy & Regulation.

Why Buy This Report?

Historical inferences, findings & analysis of the Fragment-Based Drug Discovery market from 2016 to 2018
Projections and performance forecast analysis from 2019 to 2026
Production and consumption point of view (POV) analysis
Fragment-Based Drug Discovery market drivers, restraint and opportunity analysis, to define Fragment-Based Drug Discovery market dynamics covering industry, regulatory, innovation, technological & pricing trends
Comprehensive competitive landscape mapping with recent development covering market competency, leadership, prospects, and sustainability.

In the end, this report discusses the key drivers influencing the market growth, opportunities, challenges and the risks faced by key players and the Fragment-Based Drug Discovery market as a whole. Additionally, It analyzes the emerging trends and their impact on present and future market statistics and development.

Read Report with Details @ https://straitsresearch.com/report/Fragment-Based-Drug-Discovery-Market

If you are interested in details, please contact us at sales@straitsresearch.com

About Us: Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.

About Us: Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fragment-Based Drug Discovery Market 2020 | What will be the market size and the growth rate by 2026? here

News-ID: 1897677 • Views:

More Releases from Straits Research

Comprehensive Simulation Software Market Analysis: Growth Opportunities, Key Players, and Regional Outlook by 2033
Comprehensive Simulation Software Market Analysis: Growth Opportunities, Key Pla …
The global simulation software market is witnessing unprecedented growth as digital transformation, industrial automation, and advanced engineering converge. According to the latest report by Straits Research, the global simulation software market size is estimated at USD 19.34 billion in 2025, and expected to reach USD 60.48 billion by 2033, expanding at a CAGR of 15.3% during the forecast period (2025-2033). Simulation software enables organisations to create, analyse, and test virtual models
Biotechnology Market Share to Surge by 2034 with Strong Demand in AI-Powered and Data-Driven Bio-Technologies
Biotechnology Market Share to Surge by 2034 with Strong Demand in AI-Powered and …
According to a report by Straits Research, the global biotechnology market size is estimated at USD 1,650 billion in 2025 and is projected to reach USD 5,220 billion by 2034, growing at a CAGR of 13.67% during the forecast period. Biotechnology today is no longer limited to pharmaceuticals alone it spans healthcare diagnostics and therapeutics, agriculture and food production, environmental and industrial bio-manufacturing, and bioinformatics. With the convergence of life sciences
Medical Affairs Outsourcing Market Size to Reach USD 5.28 Billion by 2033 Driven by Increasing Clinical Trials, Regulatory Complexity, and Strategic CRO Partnerships
Medical Affairs Outsourcing Market Size to Reach USD 5.28 Billion by 2033 Driven …
According to a new report published by Straits Research, The global medical affairs outsourcing market size is estimated at USD 2.15 billion in 2025 and is projected to reach USD 5.28 billion by 2033, growing at a CAGR of 11.9% during the forecast period (2025-2033). The global pharmaceutical, biotechnology, and medical device industries are undergoing rapid transformation. Increasingly complex drug development processes, rising R&D costs, and stringent regulatory frameworks are pushing
Global Respiratory Protective Equipment Market Size to Reach USD 27.39 Billion by 2033 | Rising Industrial Safety Standards and Healthcare Demand Drive Growth
Global Respiratory Protective Equipment Market Size to Reach USD 27.39 Billion b …
According to the latest analysis by Straits Research, the Global Respiratory Protective Equipment (RPE) Market size is estimated at USD 14.47 Billion in 2025 and is projected to reach USD 27.39 Billion by 2033, exhibiting a steady CAGR of 8.3% (2025-2033). Respiratory Protective Equipment (RPE) refers to devices designed to safeguard users from inhaling harmful contaminants dust, fumes, vapors, and infectious agents across high-risk industries. These include air-purifying respirators (APR), supplied-air

All 5 Releases


More Releases for Fragment

Gene Fragment Market Size, Share and Growth Report, 2034
" The global gene fragment market is projected to reach approximately $8.5 billion in 2024, driven by advances in molecular biology, synthetic biology, and personalized medicine. The forecast period from 2025 to 2034 anticipates robust growth, with market values expected to surge to around $18 billion by 2034. This translates to a Compound Annual Growth Rate (CAGR) of approximately 9.5%." Exactitude Consultancy., Ltd. released a research report titled "Gene Fragment Market".
DNA Fragment Synthesis Market to Witness Growth by 2024-2030
DNA fragment synthesis has emerged as a critical technology in the field of molecular biology and biotechnology, enabling the custom design and assembly of DNA sequences. This market is driven by the increasing demand for synthetic DNA in various applications, including gene editing, synthetic biology, and molecular diagnostics. The technology facilitates the creation of bespoke DNA fragments, offering researchers and biotech companies unprecedented control over genetic material. As the life
Global Fragment-Based Drug Discovery Market Outlook 2031
𝗚𝗹𝗼𝗯𝗮𝗹 𝗙𝗿𝗮𝗴𝗺𝗲𝗻𝘁-𝗕𝗮𝘀𝗲𝗱 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗢𝘂𝘁𝗹𝗼𝗼𝗸 𝟮𝟬𝟯𝟭 The global fragment-based drug discovery (FBDD) market is poised for remarkable growth, with a projected compound annual growth rate (CAGR) of 11.5% from 2023 to 2031. This innovative approach to early-stage drug development has gained substantial attention due to its ability to revolutionize the way we discover and develop new therapeutic agents. In 2022, the FBDD market was valued at US$ 795.4 million, and
Fragment-based Drug Discovery Market - Harnessing Fragment Power: Fueling Innova …
Newark, New Castle, USA - new report, titled Fragment-based Drug Discovery Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Fragment-based Drug Discovery market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Fragment-based Drug Discovery market. The report offers an overview of
Fragment-based Drug Discovery Market Key Trends & Industry Forecast 2015 - 2023
38.4% of the global fragment-based drug discovery market was collectively held by its top three players in 2014. Astex Pharmaceuticals, Charles River Laboratories International, Inc., and Sygnature Discovery were the key contributors to the market revenue at the time and are expected to retain their lead in the near future. A new research report released by Transparency Market Research states that with 52.3% of the global fragment-based drug discovery market
Fragment-based Drug Discovery Market USD 650 Million by 2020
The global fragment-based drug discovery market is estimated to reach USD 650 Million in 2020, growing at a CAGR of 10.6% from 2016 to 2020, according to a market research report Fragment-based Drug Discovery Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Fragment-based Drug Discovery Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/fragment-based-drug-discovery-market/ The global fragment-based drug discovery market segmentation is based on service types or components (comparative analysis of FBDD and HTS, fragment